Bezlotoxumab - A new agent for clostridium difficile infection

Research output: Contribution to journalEditorial

LanguageEnglish (US)
Pages381-382
Number of pages2
JournalNew England Journal of Medicine
Volume376
Issue number4
DOIs
StatePublished - Jan 26 2017

Fingerprint

Pseudomembranous Enterocolitis
Clostridium Infections
Clostridium difficile

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Bezlotoxumab - A new agent for clostridium difficile infection. / Bartlett, John G.

In: New England Journal of Medicine, Vol. 376, No. 4, 26.01.2017, p. 381-382.

Research output: Contribution to journalEditorial

@article{2824cef6e758441ea27de15b81fc3382,
title = "Bezlotoxumab - A new agent for clostridium difficile infection",
author = "Bartlett, {John G.}",
year = "2017",
month = "1",
day = "26",
doi = "10.1056/NEJMe1614726",
language = "English (US)",
volume = "376",
pages = "381--382",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "4",

}

TY - JOUR

T1 - Bezlotoxumab - A new agent for clostridium difficile infection

AU - Bartlett,John G.

PY - 2017/1/26

Y1 - 2017/1/26

UR - http://www.scopus.com/inward/record.url?scp=85010953522&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85010953522&partnerID=8YFLogxK

U2 - 10.1056/NEJMe1614726

DO - 10.1056/NEJMe1614726

M3 - Editorial

VL - 376

SP - 381

EP - 382

JO - New England Journal of Medicine

T2 - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 4

ER -